7.62
price up icon1.74%   0.13
after-market Handel nachbörslich: 7.53 -0.09 -1.18%
loading

Decoy Therapeutics Inc Aktie (DCOY) Neueste Nachrichten

pulisher
Mar 12, 2026

Decoy Therapeutics partners with Quantori on AI peptide platform - Investing.com India

Mar 12, 2026
pulisher
Mar 11, 2026

Equity in earnings of Decoy Therapeutics Inc. – GETTEX:FP11 - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Decoy Therapeutics partners with Quantori on AI peptide platform By Investing.com - Investing.com Nigeria

Mar 11, 2026
pulisher
Mar 11, 2026

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - marketscreener.com

Mar 11, 2026
pulisher
Mar 11, 2026

Decoy Therapeutics (DCOY) Partners with Quantori to Enhance Anti - GuruFocus

Mar 11, 2026
pulisher
Mar 11, 2026

Decoy Therapeutics enters collaboration with Quantori - TipRanks

Mar 11, 2026
pulisher
Mar 11, 2026

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform – NEWSnet Michigan - michigan.newsnetmedia.com

Mar 11, 2026
pulisher
Mar 11, 2026

Google Cloud-funded AI aims up to 100-fold faster antiviral peptide design - Stock Titan

Mar 11, 2026
pulisher
Mar 11, 2026

Current ratio of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Return on assets % of Decoy Therapeutics Inc. – MUN:FP11 - TradingView

Mar 11, 2026
pulisher
Mar 10, 2026

Salarius announces planned corporate name change to Decoy Therapeutics - MSN

Mar 10, 2026
pulisher
Mar 09, 2026

Market Movers | Winners: RVPH, DCOY, ADTX | Losers: RBOT, OLMA, BNAI - Trefis

Mar 09, 2026
pulisher
Mar 06, 2026

Decoy Therapeutics to implement 1-for-12 reverse stock split By Investing.com - Investing.com Canada

Mar 06, 2026
pulisher
Mar 05, 2026

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split - Finviz

Mar 05, 2026
pulisher
Mar 05, 2026

Decoy Therapeutics Announces Reverse Stock Split to Maintain Listing - TipRanks

Mar 05, 2026
pulisher
Mar 05, 2026

Decoy Therapeutics to implement 1-for-12 reverse stock split - Investing.com

Mar 05, 2026
pulisher
Mar 02, 2026

SLRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 02, 2026
pulisher
Feb 26, 2026

Decoy Therapeutics (DCOY) Stock Analysis Report | Financials & Insights - Benzinga España

Feb 26, 2026
pulisher
Feb 26, 2026

Decoy Therapeutics shareholders approve reverse stock split and equity plan - Investing.com Nigeria

Feb 26, 2026
pulisher
Feb 25, 2026

Decoy Therapeutics shareholders approve reverse stock split and equity plan By Investing.com - Investing.com India

Feb 25, 2026
pulisher
Feb 25, 2026

Decoy Therapeutics Shareholders Approve Plan and Reverse Split - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

DCOY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

DCOY Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 24, 2026
pulisher
Feb 11, 2026

Decoy Therapeutics Joins Webull Corporate Connect Service Platfo - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Decoy Therapeutics Joins Webull Corporate Connect Service Platform - marketscreener.com

Feb 11, 2026
pulisher
Feb 05, 2026

Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Finviz

Feb 05, 2026
pulisher
Feb 04, 2026

Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement - Finviz

Feb 04, 2026
pulisher
Jan 23, 2026

Decoy Therapeutics (DCOY) Stock Price, News & Analysis - MarketBeat

Jan 23, 2026
pulisher
Jan 23, 2026

This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Jan 23, 2026
pulisher
Jan 23, 2026

Decoy Therapeutics (DCOY) Receives "Buy" Rating from Ladenburg T - GuruFocus

Jan 23, 2026
pulisher
Jan 16, 2026

Hanish, director at Salarius, sells shares worth $17 By Investing.com - Investing.com Nigeria

Jan 16, 2026
pulisher
Jan 16, 2026

DCOY Stock Price, News & Analysis - Stock Titan

Jan 16, 2026
pulisher
Jan 14, 2026

Decoy Therapeutics Inc Share Price USD0.0001 - Hargreaves Lansdown

Jan 14, 2026
pulisher
Jan 13, 2026

DCOY Stock Price and Chart — NASDAQ:DCOY - TradingView — Track All Markets

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Inc. (DCOY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 13, 2026
pulisher
Jan 13, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Reaches Global Access Commitment Agreement With Gates Foundation; Stock Up - Nasdaq

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Faces Challenges Amid Market Fluctuations - StocksToTrade

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Faces Major Headwinds Amid Financial Struggles - timothysykes.com

Jan 13, 2026
pulisher
Jan 13, 2026

DCOYDECOY THERAPEUTICS INC Latest Stock News & Market Updates - Stock Titan

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics reaches global access commitment agreement to focus on development of a globally accessible, scalable peptide-conjugate manufacturing platform - marketscreener.com

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics rises as Gates Foundation backs antiviral drug access - TradingView

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Reaches Global Access Commitment Agreement To Focus On Development Of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - TradingView — Track All Markets

Jan 13, 2026
pulisher
Jan 13, 2026

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - PR Newswire

Jan 13, 2026
pulisher
Jan 12, 2026

Salarius Pharmaceuticals shareholders re-elect directors and approve proposals at annual meeting - Investing.com Nigeria

Jan 12, 2026
pulisher
Jan 10, 2026

What is the current Price Target and Forecast for Decoy Therapeutics Inc (DCOY) - Zacks Investment Research

Jan 10, 2026
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):